This group includes scientists who apply cutting-edge structural and cell biology techniques to study fundamental cellular processes in normal and diseased conditions, and in microbial pathogens. These studies provide molecular detail of interactions between cellular components involved in cell division, locomotion, muscle contraction, gene expression, host-pathogen interaction, and cancer. The goals are to not only understand how disease develops, but also to identify novel drug targets and mechanisms of drug resistance. Techniques include, x-ray crystallography, NMR, high-resolution cryo-electron microscopy, laser-based cellular dissection combined with light-microscopy, and computational biology, in addition to common biochemistry and molecular biology approaches.
Associated Researchers
Rajendra K. Agrawal, Ph.D.
Director, Division of Translational Medicine, Wadsworth Center
Nilesh Banavali, Ph.D.
Structure-based Therapeutics for Infectious Diseases
We use NextGen sequencing to determine frequencies and sequence dependence of polymerase errors, and computational methods for drug design, structure prediction, and elucidating chemical and conformational mechanisms.
Ye Ding, Ph.D.
RNA Bioinformatics
Alexey Khodjakov, Ph.D.
Cellular and Molecular Basis of Diseases - Mitosis
Janice D. Pata, Ph.D.
Polymerases, Mutations, and the Evolution of Antimicrobial Drug Resistance
We study the molecular mechanisms by which multiple DNA polymerases replicate bacterial genomes completely, with high accuracy and tolerance for DNA damage, yet also create mutations that give rise to antibiotic resistance.